ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer

Eunju Kim(University of Nebraska–Lincoln), Zheng Chen(The University of Texas Health Science Center at Houston)
Cell Death and Disease
April 19, 2022
Cited by 65


Related Papers